toggle

Amarin Corp

Latest Amarin Corp News and Updates

Healthcare
Amarin Stock Drops After Vascepa Appeal Hearing
Amarin stock dropped 31 percent yesterday in response to the company’s Vascepa appeal hearing.
By Ambrish ShahSept. 3 2020, Updated 11:33 a.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2025 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Amarin Corp

Amarin Stock Drops After Vascepa Appeal Hearing